Paris-based VC firm HCVC just announced the final closing of its second fund, simply called “Fund II.” And the team has managed to raise $75 million (€69 million) so that it can back pre-seed and seed ...
Paris, May 28, 2025 (GLOBE NEWSWIRE) -- One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects. Biotechnology company kyron.bio today ...
Company founded by former head of Core Automation Engineering at TESLA Accelerate the development of VITESSE™, the first no-code automated manufacturing platform Round led by HCVC (Hardware Club) LOS ...
Add Yahoo as a preferred source to see more of our stories on Google. Paris-based VC firm HCVC just announced the final closing of its second fund, simply called “Fund II.” And the team has managed to ...
The company has developed the first-ever platform to unlock precision control over glycans, essential sugar molecules found on the surface of a therapeutic. This innovation paves the way for safer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results